MIRA Pharmaceuticals
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. over the previous period. Total operating expenses were $8,526,050.
Profit Margin
| 2020 | 0 | -67.99K | |
|---|---|---|---|
| 2021 | 0 | -2.17M | |
| 2022 | 0 | -7.05M | |
| 2023 | 0 | -11.98M |
MIRA Income Statement (2020 – 2023)
| 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|
Revenue | ||||
Revenue | 0 | 0 | 0 | 0 |
Cost of revenue | 8.52M | 0 | 0 | 0 |
Gross profit | -8.52M | 0 | 0 | 0 |
Operating exp. | ||||
Research and development | 1.57M | 2.35M | 684.44K | 14.64K |
Selling and marketing | 453.55K | 0 | 0 | 52.82K |
Total operating expenses | 8.52M | 7.04M | 2.15M | 67.62K |
Operating income | -8.52M | -7.04M | -2.15M | -67.63K |
Other income (expenses), net | -3.45M | -10.25K | -24.37K | 134.89K |
Income before tax | -11.98M | -7.05M | -2.17M | -67.99K |
Income tax expense | 0 | -7.04K | -2.15K | -202 |
Net income | -11.98M | -7.05M | -2.17M | -67.99K |
Earnings per share | ||||
Basic EPS | -0.65 | -0.48 | -0.15 | -0.00 |
Diluted EPS | -0.65 | -0.48 | -0.15 | -0.00 |
| Data source |